SCAI-005

N/A

Report date: 2025/05/19 20:00:42

Base Information

Drug NameSCAI-005
Drug Alias NameAxitinib (Scai Therapeutics)SCAI-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor inhibitors
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesScai Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesScai Therapeutics
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A